News, Resources, and Events Tagged 'Intellectual Property'
Please join us for the Third Annual Health Law Year in P/Review symposium, with leading experts discussing major developments during…Read More
From the article: Traditional public choice theory postulates that interest group representation is primarily responsible for the passage of legislation in a variety of areas. Intellectual property scholars have largely…Read More
Deadline: Rolling admission.
Journal of Law and the Biosciences (JLB) is actively soliciting original manuscripts, responses, essays, and book reviews devoted to the examination of issues related to the intersection of law and biosciences, including bioethics, neuroethics, genetics,…Read More
Going further than any state so far, Vermont on Wednesday passed a lawrequiring the labeling of foods that contain genetically engineered ingredients. Though the move came in a tiny state far…Read More
The Ebola outbreak in West Africa is terrifying because there's no drug to treat this often fatal disease. But the disease is so rare, there's no incentive for big pharmaceutical companies to…Read More
Petrie-Flom Academic Fellow Nicholson Price has been appointed as an Assistant Professor at the University of New Hampshire School of Law, where he will research and teach on intellectual property, innovation policy, and…Read More
From the review: Patent applicants seeking to gain global patent protection beyond their home country borders need a better comparative knowledge of key elements of the patent laws of the several…Read More
Abstract: This perspective-article provides an overview on selected legal aspects of biobanking. It discusses these issues with a focus on public biobanks in a university setting and the specific challenges posed…Read More
Science and technology plays an increasingly important role in the continued development of international economic law. This book brings together well-known and rising scholars to explore the status and interaction…Read More
A bitter fight in Washington state over whether to label foods with ingredients that have been genetically modified has attracted tens of millions of dollars in spending, more than $27…Read More
ABOUT THE SPEAKER Chris Hansen joined the ACLU in 1973. He spent 10 years at the NYCLU specializing in complex litigation seeking reform of the mental retardation and mental health…Read More
"'M&M chocolate candies are made with a precision far beyond the capabilities of many drug manufacturers.' This is the intriguing opening to a thorough critique of innovation in pharmaceutical manufacturing by Nicholson…Read More
In June 2013, the Supreme Court held that naturally occurring gene sequences and their naturally occurring derivatives are not patent eligible. This link includes a brief summary of the case,…Read More
Shortly after the Supreme Court ruling in Myriad, this article summarizes the implications of the decision and its influence on the biotech industry.Read More
Issues and Case Studies in Clinical Trial Data Sharing:
What Have We Learned?
Objectives: To convene key global stakeholders on a neutral platform to review evidence from recent case studies in clinical trial…Read More
This article addresses misconceptions regarding gene patents and whole-genome sequencing.Read More
In this case, the Supreme Court held that the processes involved in a test for proper dosages of drug treatments are unpatentable laws of nature.Read More
This article discusses the implications of the Mayo v. Prometheus decision, including its potential impact on gene patents. It also suggests possible routes that Congress can take on the issue…Read More
This panel examined current legislative debates concerning the development of regulatory approval processes for follow-on biologics, or large molecule drugs that…Read More